• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RANGER; CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RANGER; CATHETER, PERCUTANEOUS Back to Search Results
Model Number 1177-01
Device Problems Entrapment of Device (1212); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/05/2023
Event Type  malfunction  
Event Description
It was reported that the balloon catheter became entrapped on the guidewire.A v-18 control wire and 8.0 mm x 80 mm, 135 cm ranger balloon were selected for use in a percutaneous transluminal angioplasty procedure.The balloon was unable to be advanced on the guidewire; therefore, the balloon never entered the patient.The guidewire and balloon were removed together, and the procedure was completed using a new guidewire and new ranger balloon.There were no patient complications.
 
Manufacturer Narrative
E1, initial reporter phone: (b)(6).Device eval by manufacturer: upon receipt at our post market quality assurance laboratory, this ranger balloon catheter was visually and microscopically examined.Visual examination revealed that the inflation lumen and guidewire lumen was separated 129.6cm from the hub.The end of the separation appeared to have been stretched prior to separating.There was buckling to the inflation lumen 10cm from the tip and buckling to the guidewire lumen 7mm from the tip.Microscopic examination revealed damage to the tip.Inspection of the remainder of the device presented no other damage or irregularities.Product analysis found damage that would have contributed to the froze on wire.
 
Event Description
It was reported that the balloon catheter became entrapped on the guidewire.A v-18 control wire and 8.0 mm x 80 mm, 135 cm ranger balloon were selected for use in a percutaneous transluminal angioplasty procedure.The balloon was unable to be advanced on the guidewire; therefore, the balloon never entered the patient.The guidewire and balloon were removed together, and the procedure was completed using a new guidewire and new ranger balloon.There were no patient complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RANGER
Type of Device
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
HEMOTEQ AG
adenauerstrasse 15
wuerselen 52146
GM   52146
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17396519
MDR Text Key319935277
Report Number2124215-2023-39576
Device Sequence Number1
Product Code ONU
Combination Product (y/n)Y
Reporter Country CodeUK
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 10/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number1177-01
Device Catalogue Number1177-01
Device Lot Number02059H23
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/25/2023
Initial Date FDA Received07/26/2023
Supplement Dates Manufacturer Received10/10/2023
Supplement Dates FDA Received10/17/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/03/2023
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Treatment
V-18 GUIDEWIRE; V-18 GUIDEWIRE
-
-